INTRODUCTION
PCs (prohormone/proprotein convertases) are a group of calciumdependent serine endoproteases that are related to yeast kexin and bacterial subtilisin [1] . In mammals, seven PC members have been identified so far and these include PC2, PC1/3, furin, PACE4 (paired basic amino acid cleaving enzyme 4), PC5/6, PC7/8 and PC4 [1] [2] [3] . While four of the PCs, furin, PACE4, PC5/6 and PC7/8, are widely distributed, PC2 and PC1/3 are primarily expressed in neuroendocrine/endocrine tissues and PC4 is expressed only in germ cells [1] [2] [3] [4] . PCs post-translationally and endoproteolytically process numerous inactive protein precursors to generate smaller peptides and the biological substrates for PCs include various prohormones, proneuropeptides, growth factors and growth factor receptors, adhesion molecules, matrix metalloproteinases, viral coat proteins and bacterial toxins [1] [2] [3] 5, 6] . PCs in general cleave at the C-terminus of a pair of basic (KR↓/RR↓, more rarely at KK↓/RK↓) or a single basic (K↓/R↓) site without or with upstream basic residues (R or K) at the P4, P6 or P8 positions [1] [2] [3] 7, 8] . However, other amino acids present at or near a cleavage site are likely to confer specificity for PC-mediated protein precursor processing [9] .
Unlike PC2 and PC1/3 for which null and viable animal models are available [10, 11] , investigating physiological function of the widely distributed PCs in animal models is difficult, since furin or PACE4-null mice die early in embryonic development [12] [13] [14] [15] . A recent study on homozygous deletion of PC5/6 catalytic domain shows early embryonic lethality in mice [16] . PC5/6 has two isoforms, A (soluble) (915 amino acids) and B (membrane-bound) (1877 amino acids), of which A is sorted to both the regulated and constitutive secretory pathways, while the C-terminally extended B isoform is localized in the Golgi [17] [18] [19] . PC5/6A having a shorter C-terminal CRD (cysteine-rich domain) is shown to interact with TIMPs (tissue inhibitors of metalloproteinases), indicating a potential role of this convertase to cleave protein precursors that are localized at the cell surface [18] . Our previous studies and those of others have shown that PC5/6A shares specificities with PC2 and/or PC1/3, the two neuroendocrine-specific convertases, in cleaving several important hormone and neuropeptide precursors including proglucagon, pro-GHRH (pro-growth hormone-releasing hormone), pro-NT/NN (proneurotensin/neuromedin) and pro-CCK (pro-cholecystokinin) [20] [21] [22] [23] [24] [25] .
CART (cocaine-and amphetamine-regulated transcript) is an important anorexigenic peptide and is expressed in the hypothalamus [26, 27] . It has recently been implicated in the regulation of secretion of islet hormones, including insulin [28] . CART was first cloned in the rat [29] and later in human [30] . The mouse Cart gene was then identified [31] based on its sequence similarity to the rat and human cDNAs. While both rats and mice express two pro-CART isoforms, long (102 amino acids) and short (89 amino acids), produced from a single-copy Cart gene, only the short isoform is found in humans [30] ( Figure 1A ). The long isoform has an extra 13-amino-acid stretch (residues 27-39) ( Figure 1A ) and is generated by alternative splicing [29] . Both isoforms have a common N-terminal signal peptide of 27 amino acids [29, 30] , which is deleted following their entry into the secretory pathway like most other neuroendocrine precursors [32] . In our earlier
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In the present study, we have developed PC5/6-silenced GH3 cells by RNAi (RNA interference) in order to examine the roles of PC5/6 on pro-CART processing.
EXPERIMENTAL

Materials
Both the long (102 amino acids) and short (89 amino acids) rat pro-CART-expressing constructs, CART antibodies including the monoclonal antibody against the CART peptide (amino acids ) and the recombinant CART peptides were gifts from Dr L. Thim, Dr S. Hastrup and Dr J. T. Clausen (Novo Nordisk, Bagsvaerd, Denmark). The rabbit antisera against human PC5/6 peptide (N-terminal) were gifts from Dr Robert Day (University of Sherbrooke, Sherbrooke, Canada). The polyclonal antibodies against PC2 and PC1/3 were raised in our laboratory. The rabbit antisera against 7B2 peptide were gifts from Dr Iris Lindberg (Louisiana State University Health Science Center, New Orleans, U.S.A.). RNAi-Ready pSIREN-Shuttle vector was purchased from BD Biosciences Clontech (Palo Alto, CA, U.S.A.). The mammalian expression vector, pcDNA3.1, the transfection reagent, Lipofectamine TM 2000, the Superscript first-strand synthesis system for RT (reverse transcriptase)-PCR and all the cell-culture media and reagents were bought from Invitrogen (Carlsbad, CA, U.S.A.). The transfection reagent, Effectene, and the Endo-free plasmid purification kit and Total RNeasy kit were bought from Qiagen (Valencia, CA, U.S.A.).
Cell culture, metabolic labelling, IP (immunoprecipitation) and WB (Western blotting)
GH3 cells were cultured in F10 medium containing 10 % (v/v) foetal bovine serum. Cells were dissociated in an enzyme-free Hanks-based buffer (cell dissociation buffer) for propagation. Metabolic labelling using [ 35 S]Met (150 µCi/ml), IP and WB of pro-CART and its various processed forms were performed as described previously [33] . The band intensities of various CART peptides following separation in gels were determined by densitometric scanning using 1D Image Analysis software (Kodak, Rochester, NY, U.S.A.). For WB of PC5/6A, equal numbers of cells were boiled directly in 1 × Laemmli sample buffer (200 µl) containing 5 % (v/v) 2-mercaptoethanol for 10 min, and following a brief centrifugation in a microcentrifuge at 12 000 g, equal volumes (40 µl) of whole cell lysates were resolved by SDS/8 % PAGE and peptides were transferred on to Hybond-P membrane (Amersham Biosciences, Little Chalfont, Bucks., U.K.). Peptides were incubated with the rabbit polyclonal antibody against PC5/6 (Alexis Biochemicals, San Diego, CA, U.S.A.) and the immunoreactive bands were detected by ECL ® (enhanced chemiluminescence).
Synthesis of shRNA (short hairpin RNA) and transient transfection
Different segments of the coding region of mouse PC5/6 cDNA (GenBank ® accession number L14932), excluding the 5 -and 3 -UTRs (untranslated regions), were selected to design several shRNA target sequences corresponding to the motif, AA (N19) NN, where N is any nucleotide [34] [35] [36] (Figure 1B , panel b). Each target sequence [annealed complementary oligonucleotides with an orientation of (5 )-sense-hairpin loopantisense-(3 ) sequences] was cloned downstream of a Pol III promoter (U6) [37] [38] [39] in a plasmid expression vector (see the Materials subsection). We ligated annealed oligonucleotides into the pSIREN-Shuttle vector following the manufacturer's instructions and finally transformed into DH-5α competent cells (Invitrogen) for large-scale DNA purification. Several different shRNA expression constructs, including experimental ( Figure 1B ) and control (luciferase) (supplied by BD Biosciences-Clontech), were generated. Each shRNA was transiently transfected in GH3 and GH3-CART cells overexpressing short pro-CART (89 amino acids). To generate GH3-CART cells stably overexpressing short pro-CART (89 amino acids), we subcloned the small pro-CART cDNA in a mammalian expression vector, pcDNA3.1/Zeo (Invitrogen), and following transient transfection of the recombinant plasmid in GH3 cells, we grew several individual clones under the selection of zeocin and the clone expressing maximum levels of CART peptides was selected for further studies.
RT-PCR
Total RNA for each sample was extracted from equal numbers of cells grown in a 60 mm dish using the RNeasy mini kit from Qiagen. The first strand cDNA was synthesized from 1 µg of total RNA for all the genes including PC5/6, furin, PACE4 and β-actin using the Superscript first-strand RT-PCR kit. Equal amounts of first strand cDNA were amplified by PCR using specific forward and reverse primers for each gene. We used 30-35 PCR cycles for amplification of all the genes except for β-actin where 25 cycles were employed.
RESULTS
To investigate the roles of PC5/6 in pro-CART processing, we generated transient PC5/6-null GH3 cells using plasmid vectormediated shRNAs (see the Experimental section for details). We employed GH3 cells because of higher levels of PC5/6 and low amounts of both PC2 and PC1/3 mRNA expression (see Figures 2A and 2B) [40]. We examined the protein levels for both PC2 and PC1/3 in GH3 cells by immunoblotting and found low levels (results not shown) as shown previously [41] . The GH3 somatolactotroph cells expressing growth hormone were derived from rat pituitary anterior lobe [42] . The rat anterior pituitary lobe has considerable levels of PC5/6 mRNA [43] . To investigate the effects of PC5/6 silencing on pro-CART processing, we generated seven experimental shRNA expression plasmids (see the Experimental section and Figure 1B) . We show that three are particularly effective following individual transfection and cause silencing of PC5/6 gene expression in both GH3 and GH3-CART cells expressing small pro-CART, as measured by RT-PCR, and the constructs are 584-shRNA (III), 1851-shRNA (IV) and 2542-shRNA (VII) ( Figures 2C, panel a, and 2D, panel a) . We examined the levels of β-actin and other PC genes, including furin and PACE4, by RT-PCR and found no significant changes in their levels of expression ( Figures 2C, panels b-d, and 2D, panels bd) . We found comparable levels of both PC2 and PC1/3 following shRNA transfection as shown in non-transfected parental GH3 cells (see Figure 2B) . The results altogether indicate specificity of RNAi in silencing PC5/6 gene expression.
To examine PC5/6 protein levels following RNAi-mediated silencing, we performed WB using GH3 or GH3-CART cells stably overexpressing short pro-CART (89 amino acids). We show that construct III is particularly effective in silencing PC5/6 expression relative to the other shRNA constructs examined ( Figure 2E ). We found comparable levels of tubulin for all the samples, indicating equal loading of whole cell lysates (results not shown). In our immunoblot studies using the polyclonal antibody against PC5/6 (see the Experimental section), we detected primarily the PC5/6A isoform as shown previously [17, 22] . It is likely that these neuroendocrine cells have very low endogenous levels of the PC5/6B isoform which are below the detection limits of this antibody.
Next, we examined the effects of transient silencing of PC5/6 expression in processing both the rat pro-CART isoforms, long (102 amino acids) and short (89 amino acids). PC5/6A cleaves neuroendocrine precursors at pairs of basic or single basic sites without or with upstream basic residues [20] [21] [22] [23] [24] . PC5/6 is expressed in the hypothalamus [43] and its A isoform is often co-expressed with PC2 and/or PC1/3 in various endocrine/ neuroendocrine tissues, including the hypothalamus [17, 23, 25] . To analyse whether PC5/6A has any significant ability to cleave the pro-CART isoforms, we transiently co-transfected GH3 cells with long pro-CART expression vector and either luciferaseshRNA (negative control) or 584-shRNA (III) expression plasmid ( Figure 3A) . Also, we transiently transfected GH3-CART cells overexpressing small pro-CART (see the Experimental section) with luciferase-shRNA or 584-shRNA ( Figure 4A ). The densitometric scanning data show that the levels of CART I (amino acids 55-102) and CART II (amino acids 62-102) generated from long pro-CART in GH3 cells are inhibited 2.3-and 1.9-fold respectively in the presence of the 584-shRNA relative to the luciferase control ( Figure 3B ). Similarly the scanning data of short pro-CART processing exhibit 2-fold lower production of CART I (amino acids 42-89) in GH3-CART cells by the 584-shRNA relative to the control ( Figure 4B ). The findings taken together suggest significant yet moderate impairment of bioactive CART production from the two pro-CART isoforms due to silencing of PC5/6A expression and indicate functional redundancy primarily between PC5/6A and PC2 (PC2 > PC5/6A) in cleaving the bioactive CART fragments, I and II ( Figure 5) . The results also demonstrate lack of any major defects in processing of the intermediate CART (amino acids 33-102) from long pro-CART in the presence of the 584-shRNA (Figure 3) , 1 µg) , control (luciferase) or experimental, as described in the Experimental section. Total RNA was extracted from each sample and first strand cDNAs were amplified as described in the Experimental section to examine the levels of PC5/6 (363 bp), β-actin (540 bp), furin (298 bp) and PACE4 (157 bp) genes. Lanes 2-7 in (C and D) represent the following shRNAs: luciferase, I, II, III, IV and V respectively and lane 8 in (C) represents VII. We found the construct VI ineffective in silencing PC5/6 expression and is thus not included here. We have used different forward and reverse primers for β-actin, generating a larger fragment compared with (A and B) . (E) Analysis of PC5/6 protein levels following RNAi-mediated silencing. Equal numbers of cells were transiently transfected with different individual shRNA in various amounts as shown and cells were lysed and whole cell lysates were immunoblotted as described in the Experimental section. The major immunoreactive PC5/6A band of 117 kDa [17] , detected by ECL ® , is present significantly in lane 2 (luciferase control), lanes 3 and 4 (1851-shRNA) and lane 6 (241-shRNA) relative to lane 5 (1851-shRNA) and lanes 7-9 (584-shRNA). Lane 1 represents the locations of the pre-stained high-molecular-mass marker.
suggesting that PC5/6A preferentially cleaves the pairs of basic sites, KR↓/KK↓, of the CART precursor isoforms (Figures 3-5) . CART II could not be detected in GH3-CART cells possibly due to inefficient cleavage by the rather low endogenous levels of PC2 in these cells as compared with the αTC1-6 cells that were employed for CART II detection in the initial studies [33] . The findings help to explain our previous in vivo results showing that while intermediate CART production in PC1/3-null hypothalamus is severely affected, production of bioactive CART fragments remains comparable with that in normal littermates [33] . Thus the low levels of both forms of bioactive CART (CART I > CART II) found in both PC2 and 7B2-null animals indicate overlapping specificities of PC2 more with PC5/6A than PC1/3 in processing the pairs of basic sites, KR↓and KK↓, of pro-CART ( Figure 5 ).
DISCUSSION
In the present study, we have analysed processing defects of both the rat pro-CART isoforms, long (102 amino acids) and short (89 amino acids), using RNAi-mediated PC5/6-null GH3 cells. We show that PC5/6A is functionally redundant more with PC2 (PC2 > PC5/6A) than PC1/3 in cleaving the pairs of basic sites, KR (53, 54/40, 41)↓ and KK (60, 61/47, 48)↓, of both pro-CART isoforms and thus production of the bioactive fragments, I and II, is significantly but moderately affected. Our results also demonstrate unimpaired generation of intermediate CART (amino acids 33-102) indicating that PC5/6A is unable to process the RXXR site, RQLR (29-32↓), within the long pro-CART. GH3 cells have much lower levels of both PC2 and PC1/3 compared with other widely used endocrine/neuroendocrine cell types such as β-TC3 (both PC2 and PC1/3 are high; see Figure 2B ), αTC1-6 (PC2 is high) and AtT20 (PC1/3 is high). Silencing of PC5/6 gene expression in the context of much lower endogenous levels of both PC2 and PC1/3 thus facilitates better analysis of the effects of PC5/6A in processing pro-CART. The results correspond to the previous findings that PC5/6A shares specificities with PC2 in processing KR residues present in proglucagon and pro-NT/NN [20, 22, 23] . PC5/6A is co-expressed with PC2 in several hypothalamic nuclei, particularly in the arcuate nucleus [23] , which is a major site of abundant CART expression [26, 44] , indicating in vivo overlapping specificities between these two convertases in processing pro-CART. In our previous studies on mouse pro-GHRH processing, we demonstrated much lower but detectable ability of PC5/6A (PC5/6A < PC1/3 furin) to cleave the N-terminal RXXR site, RMQR↓ [21] . In contrast, for a similar cleavage site, RQLR↓, located within the long pro-CART isoform, silencing of PC5/6A expression fails to cause any appreciable processing defects, suggesting likely effects of other residues at or near a cleavage site in influencing specificity of a convertase [7, 9] . In this context, quantitative studies on the coexpression of PC2 and PC5/6A in the CART-expressing cells in the hypothalamus will be of importance. In both of our previous and present studies on pro-CART processing, we were unable to detect any significant cleavage at the other pairs of basic sites, KK (48, 49↓/35, 36↓) and RK (77, 78↓/64, 65↓). It is worth noting that a large aliphatic residue, e.g. leucine, present at the P1 position of the site KK (48, 49↓/35, 36↓) may render significant steric hindrance to a convertase from cleaving this or PC5/6A shares specificities with PC2 in cleaving the pairs of basic sites, KR (Lys, Arg) and KK (Lys, Lys), within the two pro-CART isoforms and generates both the bioactive fragments, CART I and II. The processing scheme is a modified version of our previous studies [33] based on the present findings.
similar sites, as suggested by Cameron et al. [9] . Also, in vivo cleavage at the RK (77, 78/64, 65) site possibly will not favour release of processed peptides such as 55-76/42-63 and 62-76/49-63 because these fragments will very likely remain anchored by the three disulfide linkages formed between cysteine residues that are located C-terminally in the pro-CART isoforms [45] . In our studies on pro-CART processing, we have failed to detect a smaller CART fragment, 33-52, following processing at the sites RXXR (29-32↓) and KR (53, 54↓) within the long pro-CART isoform, most likely due to very low levels of production of the fragment. The findings altogether are consistent with our previous in vivo results on pro-CART processing examining hypothalamic extracts from PC1/3, PC2 and 7B2 (an essential PC2-interacting protein)-null animals and help to explain the severe lack of the intermediate CART fragments in PC1/3-null mice compared with their normal littermates [33] . Also these results are consistent with the production of low levels of bioactive CART forms (CART I > CART II) in PC2 and 7B2-null mice relative to their normal controls.
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